Suppr超能文献

模式扫描激光全视网膜光凝术对中国患者糖尿病视网膜病变的长期影响:一项回顾性研究

Long-term effects of pattern scan laser pan-retinal photocoagulation on diabetic retinopathy in Chinese patients: a retrospective study.

作者信息

Huang Chuang-Xin, Lai Kun-Bei, Zhou Li-Jun, Tian Zhen, Zhong Xiao-Jing, Xu Fa-Bao, Gong Ya-Jun, Lu Lin, Jin Chen-Jin

机构信息

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, Guangdong Province, China.

出版信息

Int J Ophthalmol. 2020 Feb 18;13(2):239-245. doi: 10.18240/ijo.2020.02.06. eCollection 2020.

Abstract

AIM

To evaluate the long-term effects of pattern scan laser (PASCAL) pan-retinal photocoagulation (PRP) on diabetic retinopathy (DR) in Chinese patients.

METHODS

In this retrospective study, we evaluated clinical data of 29 patients (53 eyes) with severe non-proliferative DR (SNPDR) or proliferative DR (PDR) who received PRP and follow-up at our hospital from 2008 to 2013. Sixteen patients (29 eyes) received PASCAL PRP and 13 patients (24 eyes) received 100-ms conventional laser PRP.

RESULTS

After long-term follow-up (mean, min-max days: 719.8, 290-1666 for PASCAL PRP 743.5, 240-1348 for conventional PRP, =0.569), patients receiving PASCAL PRP required fewer photocoagulation sessions than the conventional PRP group (2.6±1.0 3.9±0.9, <0.01). Best corrected visual acuity (BCVA) was reduced slightly in PASCAL PRP group while reduced significantly in conventional PRP group. At last visit, 24 eyes in the PASCAL group (88.9%) and 21 eyes in the conventional group (91.7%) were improved or stable. Two eyes in PASCAL PRP group (7.4%) and 3 eyes in the conventional PRP group (12.5%) developed vitreous hemorrhage or vitreous fibrovascular proliferation.

CONCLUSION

PASCAL PRP is as effective and may be more conducive to maintaining visual acuity with less treatment sessions for DR treatment compared to conventional laser PRP.

摘要

目的

评估模式扫描激光(PASCAL)全视网膜光凝(PRP)对中国糖尿病视网膜病变(DR)患者的长期疗效。

方法

在这项回顾性研究中,我们评估了2008年至2013年在我院接受PRP治疗并随访的29例(53只眼)重度非增殖性DR(SNPDR)或增殖性DR(PDR)患者的临床资料。16例(29只眼)接受PASCAL PRP治疗,13例(24只眼)接受100毫秒传统激光PRP治疗。

结果

经过长期随访(平均,最小-最大天数:PASCAL PRP组为719.8,290 - 1666;传统PRP组为743.5,240 - 1348,P = 0.569),接受PASCAL PRP治疗的患者所需的光凝次数少于传统PRP组(2.6±1.0对3.9±0.9,P <0.01)。PASCAL PRP组最佳矫正视力(BCVA)略有下降,而传统PRP组则显著下降。在最后一次随访时,PASCAL组24只眼(88.9%)和传统组21只眼(91.7%)病情改善或稳定。PASCAL PRP组2只眼(7.4%)和传统PRP组3只眼(12.5%)发生玻璃体积血或玻璃体纤维血管增殖。

结论

与传统激光PRP相比,PASCAL PRP治疗DR同样有效,且可能更有利于在减少治疗次数的情况下维持视力。

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验